Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA for visualization and resection of malignant gliomas
NCT01445691Phase 2Withdrawn
- Start
- Nov 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in malignant glioma. Planned start Nov 2015; status: withdrawn.
02
Drugs
5-aminolevulinic acid
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT01445691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01445691.